At a glance
ClinicalIndex Comparison RecordN/ACompleted· 711 enrolled
Drug / intervention
Cognoa ASD diagnostic deviceother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cognoa ASD Diagnosis Aid Validation Study
In Brief
A clinical study evaluating Cognoa ASD diagnostic device for Autism Spectrum Disorder. Completed, enrolled 711 participants across 16 sites.
Detailed Summary
The primary objective of this study is to collect data to ascertain the Positive Predictive Value (PPV) and Negative Predictive Value (NPV) of the current version of the Cognoa diagnostic device.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
First PostedNov 2019
Primary CompletionJun 2020
Study CompletionAug 2020
TodayJul 2026
First PostedNov 5, 2019
Enrollment StartAug 7, 2019
Primary CompletionJun 5, 2020
Study CompletionAug 31, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.7 years ago
Interventions
Cognoa ASD diagnostic deviceother
Cognoa device is intended to aid healthcare providers in diagnosing Autism Spectrum Disorder (ASD)